WHO ICTRP trial

A multi-center clinical trial with parallel groups of psoriatic patients…

EUCTR2013-001632-21-HU · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2013-001632-21-HU
Public title A multi-center clinical trial with parallel groups of psoriatic patients receiving different treatments for comparison of a new topical vitamin D3 formulation with the placebo and the marketed comparator Daivonex®
Scientific title A randomized, double-blind, parallel group phase III multi-center trial to compare twice daily topical application of M518101, Daivonex® and vehicle in patients with plaque psoriasis - Vitamin D3 topical ointment study for Psoriasis
Primary sponsor Maruho Europe Limited
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Hungary;Poland;Ukraine;Romania;Lithuania;Austria;Bulgaria;Germany
Conditions Plaque psoriasis MedDRA version: 17.0 Level: LLT Classification code 10050576 Term: Psoriasis vulgaris System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
Interventions Product Name: M518101 Ointment (pefcalcitol) Product Code: M518101 Pharmaceutical Form: Ointment INN or Proposed INN: Pefcalcitol CAS Number: 381212-03-9 Current Sponsor code: M5181 Concentration unit: µg microgram(s) Concentration type…
Registration date Jul 17, 2013
Target size 725
Secondary IDs M518101-EU04;2013-001632-21-LT
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations